NOVAVAX INC | Modification Agreements | Business Contracts

Modification No. 03 to Base Agreement between the Company and Advanced Technology International, dated as of November 30, 2022 (Filed With SEC on February 28, 2023)

Modification No (Filed With SEC on November 9, 2022)

Modification No. 02 to Base Agreement between the Company and Advanced Technology International, dated as of August 2, 2022 (Filed With SEC on November 9, 2022)

Modification No. 01 to Base Agreement between Novavax, Inc. and Advanced Technology International, dated as of March 23, 2022 (Filed With SEC on May 10, 2022)

Modification No. 13 to Undefinitized Project Agreement No. 01, dated February 1, 2022, between the Company and Advanced Technology International (Filed With SEC on March 1, 2022)

Modification No. 12 to Undefinitized Project Agreement No. 01, dated December 20, 2021, between the Company and Advanced Technology International (Filed With SEC on March 1, 2022)

Modification No. 11 to Undefinitized Project Agreement No. 1, dated August 26, 2021, between Novavax, Inc. and Advanced Technology International (Filed With SEC on November 5, 2021)

Modification No. 10 to Undefinitized Project Agreement No. 1, dated August 6, 2021, between Novavax, Inc. and Advanced Technology International (Filed With SEC on November 5, 2021)

Modification No. 09 to Undefinitized Project Agreement No. 1, dated July 16, 2021, between Novavax, Inc. and Advanced Technology International (Filed With SEC on November 5, 2021)

Modification No. 08 to Undefinitized Project Agreement No. 1, dated June 4, 2021, between Novavax, Inc. and Advanced Technology International (Filed With SEC on August 5, 2021)

Modification No. 07 to Undefinitized Project Agreement No. 1, dated April 23, 2021, between Novavax, Inc. and Advanced Technology International (Filed With SEC on August 5, 2021)

Modification No. 03 to Undefinitized Project Agreement No. 01, entered into September 18, 2020, between the Company and Advanced Technology International (Filed With SEC on March 1, 2021)

Amendment of Solicitation/Modification of Contract, Modification No. 3, entered into January 5, 2021, between the Company and the U.S. Department of Defense Joint Program... (Filed With SEC on March 1, 2021)

Amendment of Solicitation/Modification of Contract, Modification No. 2, entered into December 1, 2020, between the Company and the U.S. Department of Defense Joint Program... (Filed With SEC on March 1, 2021)

Modification No. 06 to Undefinitized Project Agreement No. 01, entered into January 19, 2021, between the Company and Advanced Technology International (Filed With SEC on March 1, 2021)

Modification No. 05 to Undefinitized Project Agreement No. 01, dated January 12, 2021, between the Company and Advanced Technology International (Filed With SEC on March 1, 2021)

Modification No. 04 to Undefinitized Project Agreement No. 01, entered into December 23, 2020, between the Company and Advanced Technology International (Filed With SEC on March 1, 2021)

Modification No. 02 to Undefinitized Project Agreement No. 01, entered into September 10, 2020, between the Company and Advanced Technology International (Filed With SEC on March 1, 2021)

NOVAVAX INC (79) | Modification Agreements (20)